AzTrials
AzTrials

Newborn Basic Care TrainingNCT07159477

Effect of Skin-to-Skin Contact on Father-Infant Bonding: A Randomized Controlled Trial

A study testing Skin to Skin contact in people with Newborn Basic Care Training and Newborn Infant, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized, parallel-group clinical trial evaluates whether father-infant skin-to-skin contact improves bonding among healthy term newborns and their fathers in Türkiye. Fathers are randomly assigned to one of three arms that differ in the timing and frequency of skin-to-skin contact (early one-time contact… Read more about this study

Who is it for?
Any age, men onlyHealthy volunteers can take part
What is being tested?
Skin to Skin contact
Could I receive a placebo?
No, everyone receives an active treatment
How many people
165 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 Jan 2023to 5 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Men only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Fathers ≥18 years old
  • First-time fathers
  • At least primary school graduates
  • Able to provide ≥15 minutes of skin-to-skin contact within 4 hours of birth
  • No communication problems
  • Co-resident with their spouses
  • Infant: single, healthy newborn at 38-42 weeks' gestation and present with the mother
  • (If applicable) Infant birth weight between 2500-4000 g

Who cannot join

  • Fathers who could not be reached during data collection or follow-up
  • Separation from the infant for more than one week during follow-up (e.g., hospitalization of the father or infant, long-term work travel)
  • Infants requiring special care or with congenital anomalies/serious illness

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Çanakkale Onsekiz MArt University Hospital

    Çanakkale, 17100

Other trials in Turkey (Türkiye)

About this study

Official title: TEN TENE TEMASIN BABA-BEBEK BAĞLANMASINA ETKİSİ: RANDOMİZE KONTROLLÜ ÇALIŞMA

This randomized, parallel-group clinical trial evaluates whether father-infant skin-to-skin contact improves bonding among healthy term newborns and their fathers in Türkiye. Fathers are randomly assigned to one of three arms that differ in the timing and frequency of skin-to-skin contact (early one-time contact, frequent contact, or standard care). Bonding is assessed with a validated paternal-infant bonding scale at prespecified postpartum time points. The study enrolls fathers of newborns delivered in university and state hospital obstetrics units.

Read the detailed description

Rationale: Early skin-to-skin contact may facilitate father-infant bonding; experimental evidence in Türkiye is limited.

Design: Interventional, randomized, parallel assignment with three arms:

  • Early skin-to-skin contact: a single early skin-to-skin session.
  • Frequent skin-to-skin contact: repeated skin-to-skin sessions (e.g., ≥15 minutes per session on most days).
  • Standard care: routine postnatal care without a structured skin-to-skin schedule.Participants: Fathers ≥18 years with healthy term singleton newborns.

Assessments: Paternal-Infant bonding is measured using a validated bonding scale at baseline and at a prespecified postpartum time point (e.g., 3 months). Additional baseline questionnaires are collected.

Analysis plan (summary): Group comparisons and exploratory associations will be evaluated per protocol using appropriate statistical tests; full statistical details are provided in the Results section upon completion.

Being tested
Skin to Skin contact
Keywords
Bonding, Fathers, Newborn.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Skin to Skin contactBehavioural

    Fathers are briefed on skin-to-skin: what it is/isn't, why it matters, how to do it, and benefits for father, mother, and baby. Keep the room quiet; close windows to avoid drafts. Do not perform if the father is sleeping. Smokers must not perform while smoking and should do it before smoking when possible. After mother-infant skin-to-skin and breastfeeding, start father-infant contact within four hours of birth. If clothing is unsuitable, provide a surgical gown. Place the diapered infant upright on the father's bare chest. The father supports shoulders and back, maintains eye contact, speaks softly, and touches the baby. Cover both with a blanket; only mother, father, and infant remain, with the researcher silent. Continue at least 15 minutes; end if the father requests care or the infant needs care (diapering, dressing, breastfeeding). Repeat once for the early-contact group and at least daily until discharge for the frequent-contact group; on discharge, remind daily home practice.

Study groups in NCT07159477
Study groupRoleWhat they receive
Fathers who received standard care (SC):No interventionNo intervention was given to the fathers in this group according to their order of participation in the study. In the second interview with these fathers, after the data were collected, they were given information and brochures about skin-to-skin contact.
Early skin-to-skin contact group (ESSC):ExperimentalFathers in this group, in order to participate in the study, were allowed to have skin-to-skin contact with their babies only once and for at least 15 minutes within the first 4 hours after birth, after the mother and baby had skin-to-skin contact after the baby was born and the baby was breastfed. If the father had any questions about skin-to-skin contact, they were given an explanation, and their questions were answered.
Receives: Behavioral: Skin to Skin contact
Frequent skin-to-skin contact group (FSSC):ExperimentalFathers in this group, according to the order of participation in the study, were provided skin-to-skin contact with their babies for at least 15 minutes within the first 4 hours after birth, after which skin-to-skin contact was established between the mother and baby after the baby was born and the baby was breastfed and within the first 4 hours after birth. However, skin-to-skin contact with babies by fathers in this group was repeated at least once a day for at least 15 minutes in the hospital until the baby was discharged. After the mother and baby were discharged, fathers were asked to continue skin-to-skin contact at home for at least 15 minutes at least once a day or at least six days a week. In addition, a brochure prepared in accordance with the literature was given to these fathers.
Receives: Behavioral: Skin to Skin contact

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Paternal-Infant Attachment Scale (PIAS) Total Score at 3 Months Postpartum

    Assessed with the Paternal-Infant Attachment Scale (PIAS). The PIAS has 19 items in three subscales and yields a total score from 19 to 95 points; higher scores indicate stronger father-infant bonding. The PIAS is self-reported by fathers at the postpartum assessment.

    Measured: 3 months postpartum

Secondary outcomes (5)
  1. Patience and Tolerance Subscale Score (PIAS) at 3 Months Postpartum

    Subscale of the PIAS; higher scores indicate stronger bonding. Administered at the postpartum assessment.

    Measured: 3 months postpartum

  2. Pleasure in Interaction Subscale Score (PIAS) at 3 Months Postpartum

    Subscale of the PIAS; higher scores indicate stronger bonding. Administered at the postpartum assessment.

    Measured: 3 months postpartum

  3. Affection and Pride Subscale Score (PIAS) at 3 Months Postpartum

    Subscale of the PIAS; higher scores indicate stronger bonding. Administered at the postpartum assessment.

    Measured: 3 months postpartum

  4. Frequency of Father-Infant Skin-to-Skin Contact (days/week)

    Number of days per week fathers report skin-to-skin contact with their infants, captured by questionnaire at the postpartum assessment.

    Measured: Up to 3 months postpartum

  5. Daily Minutes of Father-Infant Skin-to-Skin Contact

    Average daily minutes of skin-to-skin contact reported by fathers at the postpartum assessment.

    Measured: Up to 3 months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2025
  2. Study start30 Jan 2023
  3. Primary completion15 Apr 2024
  4. Study completion5 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
165 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07159477
Sponsor's protocol ID
2023-YÖNP-0008
Status last verified
Aug 2025
First submitted
15 Aug 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The datasets generated and/or analysed during the current study are available on the researcher's computer. The datasets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

Publications

  • Yurdal NEO, Ozsoy S. Effect of skin to skin contact on father infant bonding in a randomized controlled trial. Sci Rep. 2025 Nov 19;15(1):40728. doi: 10.1038/s41598-025-24589-1.

    PubMed 41258333

Questions about this trial

What is this clinical trial studying?

A study testing Skin to Skin contact in people with Newborn Basic Care Training and Newborn Infant, run by Çanakkale Onsekiz Mart University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Paternal-Infant Attachment Scale (PIAS) Total Score at 3 Months Postpartum (time frame: 3 months postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07159477, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in